Kawagishi Naoki

カワギシナオキ | Kawagishi Naoki

Research field (1)： Gastroenterology

Research keywords (1)：肝炎

Research theme for competitive and other funds (1)：

2020 - 2023 C型肝炎SVR後発癌/肝線維化非改善に関与する因子の同定と治療応用

Papers (59)：

Risako Kohya, Goki Suda, Masatsugu Ohara, Takashi Sasaki, Tomoka Yoda, Naofumi Sakurai, Sonoe Yoshida, Qingjie Fu, Zijian Yang, Shunichi Hosoda, et al. Potential Correlation between Changes in Serum FGF21 Levels and Lenvatinib-Induced Appetite Loss in Patients with Unresectable Hepatocellular Carcinoma. Cancers. 2023. 15. 12
Takashi Sasaki, Goki Suda, Masatsugu Ohara, Shunichi Hosoda, Naoki Kawagishi, Risako Kohya, Tomoka Yoda, Osamu Maehara, Shunsuke Ohnishi, Sonoe Yoshida, et al. Recent prevalence and characteristics of patients with hepatitis delta virus in Hokkaido, Japan. Hepatology research : the official journal of the Japan Society of Hepatology. 2023
Shunichi Hosoda, Goki Suda, Takuya Sho, Koji Ogawa, Megumi Kimura, Zijian Yang, Sonoe Yoshida, Akinori Kubo, Yoshimasa Tokuchi, Takashi Kitagataya, et al. Low Baseline CXCL9 Predicts Early Progressive Disease in Unresectable HCC with Atezolizumab Plus Bevacizumab Treatment. Liver cancer. 2023. 12. 2. 156-170
Yoshimasa Tokuchi, Goki Suda, Naoki Kawagishi, Masatsugu Ohara, Risako Kohya, Takashi Sasaki, Tomoka Yoda, Osamu Maehara, Shunsuke Ohnishi, Akinori Kubo, et al. Hepatitis C virus eradication by direct-acting antivirals causes a simultaneous increase in the prevalence of fatty liver and hyper low-density lipoprotein cholesterolemia without an increase in body weight. Hepatology research : the official journal of the Japan Society of Hepatology. 2023. 53. 7. 595-606
Zijian Yang, Goki Suda, Osamu Maehara, Masatsugu Ohara, Tomoka Yoda, Takashi Sasaki, Risako Kohya, Sonoe Yoshida, Shunichi Hosoda, Yoshimasa Tokuchi, et al. Changes in Serum Growth Factors during Resistance to Atezolizumab Plus Bevacizumab Treatment in Patients with Unresectable Hepatocellular Carcinoma. Cancers. 2023. 15. 3

ｍore...

MISC (58)：

須田剛生, 川岸直樹, 大原正嗣, 中井正人, 荘拓也, 小川浩司, 坂本直哉. B型肝炎治療オーバービュー-Overview of treatment for hepatitis B-特集 B型肝炎診療の進歩. 消化器・肝臓内科 = Gastroenterology & hepatology / 消化器・肝臓内科編集委員会編. 2022. 12. 2. 172-174
大原正嗣, 須田剛生, 重沢拓, 鈴木和治, 中村晃久, 川岸直樹, 中井正人, 荘拓也, 森川賢一, 小川浩司, et al. 肝疾患患者における筋肉量の経時変化の評価はBIA法に比べCT画像を用いた方法が有用である. 肝臓. 2021. 62. Supplement 1
川岸直樹, 須田剛生, 中井正人, 荘拓也, 森川賢一, 小川浩司, 坂本直哉. C型肝炎患者の血清Angiopoietin-2値はDAAs治療後の肝線維化非改善例を予測する. 肝臓. 2019. 60. Suppl.2. A653-A653
大原正嗣, 須田剛生, 重沢拓, 鈴木和治, 中村晃久, 川岸直樹, 中井正人, 荘拓也, 森川賢一, 小川浩司, et al. カルニチンは肝硬変患者における筋肉量減少を抑制する. 肝臓. 2019. 60. Suppl.2. A677-A677
荘拓也, 須田剛生, 鈴木和治, 中村晃久, 大原正嗣, 川岸直樹, 中井正人, 森川賢一, 小川浩司, 坂本直哉. 進行肝細胞癌に対するレンバチニブ投与症例からみた適格使用時期の検討. 肝臓. 2019. 60. Suppl.2. A705-A705

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page